Wiley, European Journal of Immunology, 3(30), p. 778-786, 2000
DOI: 10.1002/1521-4141(200003)30:3<778::aid-immu778>3.0.co;2-i
Wiley, European Journal of Immunology, 3(30), p. 778-786
DOI: 10.1002/1521-4141(200003)30:3<778::aid-immu778>3.3.co;2-9
Full text: Download
In this study we examined the effect of the synthetic peptide thymosin- 1( T1) on MHC class I expression in FRTL-5 cells. Treatment with T 1 increased expression of MHC class I surface molecules and mRNA, which reached its peak (153 ± 8 % of the control value) after 12 h. Chloramphenicol acetyltransferase (CAT) analysis, following transfection with a plas- mid containing the regulatory sequence of MHC class I (or its deletion derivatives) with the CAT reporter gene, and electrophoretic mobility shift assay experiments demonstrated that the action of T 1 was at the transcriptional level, and its mechanism of action is likely due to increased binding between the complex p50/fra-2 and the enhancer A sequence of the 5' flanking region of a swine class I gene (PD1). An increase in the expression of MHC class I surface molecules was also observed by flow cytometry in murine and human tumor cell lines and in primary cultures of human macrophages. This study shows for the first time an effect of T 1 on the regulation of gene expression at the molecular level, and may further contribute to explaining the results obtained using T 1 in the control of infectious diseases and tumor growth.